West Pharmaceutical Services Inc. ($WST) Stock Forecast: Down 8.4% Today

What is West Pharmaceutical Services Inc.?

West Pharmaceutical Services (WST) is a company specializing in manufacturing packaging components and delivery systems for injectable drugs and healthcare products. The company operates in segments like Proprietary Products and Contract-Manufactured Products.

Why is West Pharmaceutical Services Inc. going down?

WST stock is down 8.4% on Jul 25, 2024 17:53

• Reported disappointing Q2 2024 earnings, with EPS of $1.52 missing estimates and revenue of $702.10 million falling short.
• Attributed the decline in performance to a decrease in demand for its products across segments, coupled with elevated customer destocking.
• The missed earnings and lowered outlook for 2024 could have led to a lack of investor confidence, resulting in a bearish movement in the stock price.
• Concerns may arise about the company's ability to drive growth and profitability in the face of challenging market conditions, leading to a sell-off of WST shares.

WST Price Chart

WST News

WST Stock Earnings: West Pharmaceutical Servs Misses EPS, Misses Revenue for Q2 2024

West Pharmaceutical Servs (NYSE:WST) just reported results for the second quarter of 2024. West Pharmaceutical Servs reported earnings per share of $1.52. This was below the analyst estimate for EPS of $1.74. The company reported revenue of $702.10 million. This was 3.74% worse than the analyst estimate for revenue of $729.35 million. InvestorPlace Earnings is a project that leverages data from TradeSmith to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at editor@investorplace.com.

https://investorplace.com/earning-results/2024/07/wst-stock-earnings-west-pharmaceutical-servs-for-q2-of-2024/

West Pharmaceutical ( WST ) Misses on Q2 Earnings, Lowers '24 View

West Pharmaceutical's (WST) second-quarter results reflect a declining demand for products across its segments amid elevated customer destocking.

https://www.zacks.com/stock/news/2309166/west-pharmaceutical-wst-misses-on-q2-earnings-lowers-24-view

West Pharmaceutical Services Inc (WST) Q2 2024 Earnings: EPS of $1. ...

West Pharmaceutical Services Inc (WST) Q2 2024 Earnings: EPS of $1.51 Misses Estimates, Revenue at $702.1 Million Falls Short

https://www.gurufocus.com/news/2481616/west-pharmaceutical-services-inc-wst-q2-2024-earnings-eps-of-151-misses-estimates-revenue-at-7021-million-falls-short

West Pharmaceutical Services Unveils Financial Results

West Pharmaceutical Services (WST) has issued an announcement. Westpharma has disclosed its operational and financial results, which can be accesse…

https://www.tipranks.com/news/company-announcements/west-pharmaceutical-services-unveils-financial-results

West Pharmaceutical Services Inc. Q2 Profit Decreases, Misses Estimates

West Pharmaceutical Services Inc. (WST) revealed a … second quarter. Excluding items, West Pharmaceutical Services Inc. reported adjusted earnings … .8 million last year. West Pharmaceutical Services Inc. earnings at a …

https://www.rttnews.com/3462765/west-pharmaceutical-q2-profit-misses-estimates-cuts-annual-outlook-below-view-stock-down-update.aspx

Trending Today

Ethereum ($ETH) Crypto Forecast: Up 5.1% Today

Pendle ($PENDLE) Crypto Forecast: Up 5.1% Today

Jupiter ($JUP) Crypto Forecast: Up 7.4% Today

Wormhole ($W) Crypto Forecast: Up 6.8% Today

Natural Gas ($GAS) Commodity Forecast: Up 5.1% Today

Solana ($SOL) Crypto Forecast: Up 7.3% Today

Avalanche ($AVAX) Crypto Forecast: Up 6.5% Today

Arbitrum ($ARB) Crypto Forecast: Up 5.9% Today

Aptos ($APT) Crypto Forecast: Up 10.0% Today

Chainlink ($LINK) Crypto Forecast: Up 5.1% Today

West Pharmaceutical Services Inc. Price History

16.01.2024 - WST Stock was down 14.0%

• The recent decline in WST's stock can be attributed to the following factors:
• 1. Sales Estimates: WST reported a 3.4% increase in adjusted EPS compared to the previous year. However, their quarterly sales fell short of the consensus estimate. This may have disappointed investors and impacted the stock negatively.
• 2. Organic Net Sales Growth: Investors may have perceived the 1.4% organic net sales growth as relatively low, which could have contributed to the bearish movement.
• 3. Earnings Call Reaction: Although the company reported strong growth and demand for non-COVID-19 products, the market reaction to the earnings call presentation may not have met expectations, resulting in a decline in the stock price.
• 4. Market Volatility: The healthcare sector as a whole has been experiencing volatility, which could have influenced the bearish movement in WST's stock.
• In conclusion, the recent decline in WST's stock can be attributed to missed sales estimates, relatively low organic net sales growth, the market's reaction to the earnings call, and overall market volatility in the healthcare sector.

12.05.2024 - WST Stock was up 5.4%

• WST's stock showed a significant bullish movement today.
• Short interest in WST has increased, indicating more investors are betting on a price decline.
• Despite the rise in short interest, positive market sentiment and strong fundamentals seem to be driving WST's bullish movement, potentially overriding any selling pressure from short sellers.
• Investors appear optimistic about WST's growth potential and market positioning, leading to a higher stock price despite the short interest.

16.01.2024 - WST Stock was down 14.0%

• The bearish movement in WST stock today can be attributed to the following factors:
• 1. Missed Sales Estimates: Despite exceeding earnings expectations, West Pharmaceutical Services reported quarterly sales that fell below the consensus estimate, possibly disappointing investors.
• 2. Organic Net Sales Growth: The 1.4% organic net sales growth in the fourth quarter may have raised concerns about the company's future growth potential.
• 3. Lack of Positive News: There is a absence of significant positive updates or developments for West Pharmaceutical Services, which could have contributed to the market's negative sentiment.
• 4. Overall Market Sentiment: Considering broader market conditions and sentiment is important, as they can impact individual stock movements. If the overall market is in a bearish trend, it can have a spillover effect on WST stock.

25.03.2024 - WST Stock was down 5.1%

• The company announced its recent financial results, potentially disappointing investors and causing a bearish market movement.
• Concerns over adverse currency fluctuations impacting the business's financial performance in the first quarter of 2024 may have influenced the bearish trend.
• Negative investor response to operational challenges within West Pharmaceutical Services could have fueled the significant bearish movement in the stock.

12.02.2024 - WST Stock was up 5.9%

• The insider selling of shares by VP and Chief Accounting Officer Chad Winters might have initially raised concerns among investors.
• However, the bullish movement in WST's stock could indicate that the selling activity was not perceived as a significant negative signal by the market.
• Investors may have focused more on the overall positive outlook for the company and its industry, leading to increased buying interest and driving the stock price higher.
• This suggests that despite the insider selling news, market participants remain optimistic about WST's future prospects.

15.01.2024 - WST Stock was down 13.1%

• The bearish movement in WST today can be attributed to the following factors:
• 1. Mixed Q4 Results: Despite beating the consensus estimate for adjusted EPS, West Pharmaceutical Services Inc. missed the consensus estimate for quarterly sales. This mixed performance might have disappointed investors and led to the bearish market movement.
• 2. Lower-than-Expected Sales: The company's quarterly sales growth of 3.3% fell short of the consensus estimate, indicating a potential slowdown in demand. This could have contributed to the negative sentiment surrounding the stock.
• 3. Market Expectations: With earnings releases of medical product companies approaching, including West Pharmaceutical Services, investors might have had high expectations for strong customer demand. Any perceived weakness in the company's financial results could have triggered a bearish reaction in the market.
• 4. Lack of Positive News: The absence of any significant positive developments or catalysts for the stock might have contributed to the bearish sentiment among traders.
• Overall, the bearish movement in WST today can be attributed to mixed Q4 results, lower-than-expected sales, high market expectations, and the absence of positive news.

15.01.2024 - WST Stock was down 14.0%

• The bearish movement in WST stock today can be attributed to the following factors:
• 1. Mixed Q4 results: Despite exceeding earnings expectations, West Pharmaceutical Services Inc's quarterly sales fell short of estimates. This discrepancy may have disappointed investors and led to a sell-off of the stock.
• 2. Initiating FY24 outlook: The lack of available information about West Pharmaceutical's FY24 outlook suggests uncertainty surrounding the company's future performance. This uncertainty could have contributed to the bearish sentiment among investors.
• 3. Market reaction to financial results: The release of key financial results and operational highlights may have triggered a negative market response, potentially due to concerns about the company's growth prospects or other factors mentioned.
• 4. Overall market conditions: It's important to consider that broader market conditions and investor sentiment can also influence the movement of individual stocks. If there was a general bearish sentiment in the market, it could have contributed to the decline in WST stock.

13.02.2024 - WST Stock was up 5.9%

• The surge in West Pharmaceutical's shares could be attributed to positive market sentiment and increased trading volume.
• Despite an insider selling shares, the overall market response was positive, indicating that investors may be focusing more on the company's growth potential.
• The earnings estimate revisions trend may have contributed to the bullish movement, suggesting that investors are optimistic about the company's future performance.
• The insider selling shares might not have had a significant impact on the stock price, as the positive market sentiment overshadowed this development.

07.02.2024 - WST Stock was down 0.8%

• The bearish movement in WST stock today could be attributed to the company's President and CEO selling company shares. This could have potentially signaled to investors a lack of confidence in the company's future performance.
• Investors may interpret the insider selling as a bearish signal, leading to a sell-off of WST shares and driving the stock price lower.
• The market might be reacting negatively to the perceived lack of alignment between the leadership's actions and the company's growth prospects, causing a decline in WST stock value today.

18.05.2024 - WST Stock was down 5.2%

• Investors may be eyeing WST due to its recent underperformance in the market, leading to a bearish movement.
• The key drivers of market outperformance and growth potential mentioned earlier may not have materialized as expected, causing a negative sentiment towards the stock.
• Market participants might be reevaluating their positions in WST, leading to a sell-off in the stock as investors adjust their expectations based on the company's performance.

25.06.2024 - WST Stock was down 8.4%

• Reported disappointing Q2 2024 earnings, with EPS of $1.52 missing estimates and revenue of $702.10 million falling short.
• Attributed the decline in performance to a decrease in demand for its products across segments, coupled with elevated customer destocking.
• The missed earnings and lowered outlook for 2024 could have led to a lack of investor confidence, resulting in a bearish movement in the stock price.
• Concerns may arise about the company's ability to drive growth and profitability in the face of challenging market conditions, leading to a sell-off of WST shares.

25.06.2024 - WST Stock was down 12.1%

• Today, West Pharmaceutical Services Inc. (WST) faced a substantial bearish movement in the stock market, potentially influenced by its Q2 earnings report:
• The company revealed an EPS of $1.51, missing estimates, and revenue of $702.1 million falling short, indicating a weaker financial performance than expected.
• The decline in Q2 profit and missed estimates likely contributed to investor concerns and the subsequent bearish market movement.
• Additionally, the impact of unfavorable currency movements on the company's top and bottom lines might have further dampened investor sentiment, resulting in the downward trend in WST stock.